Patents for A61P 17 - Drugs for dermatological disorders (106,455)
08/1996
08/22/1996CA2212370A1 Inhibition of angiogenesis using interleukin-12
08/22/1996CA2211674A1 Alk(en)yl dicarboxylic acid bisesters, their use and method for preparing them
08/21/1996EP0726956A1 Novel human transglutaminases
08/21/1996EP0726911A1 Treatment of immunologic and hematologic disorders with igfbp alone or complexed with igf
08/21/1996EP0726895A1 Pseudodipeptide product having an imidazole grouping and applications
08/21/1996EP0726773A1 Method for inhibiting angiogenesis using heparinase
08/21/1996EP0726764A1 Multilamellar liposomal arachidonic acid metabolite formulations
08/21/1996EP0726763A1 Methods of treatment using unilamellar liposomal arachidonic acid metabolite formulations
08/21/1996EP0614457B1 Leukotriene-b 4? derivatives, process for preparing the same and medicaments
08/21/1996CN1129447A Tri-substituted imidazoles having multiple therapeutic properties
08/21/1996CN1129441A Vitamin D analogues
08/21/1996CN1129102A Catechol diether compounds as inhibitors of TNF release
08/21/1996CN1129098A Composition for enhancing hair growth
08/20/1996US5547971 Use of leflunomide for inhibiting interleukin 8
08/20/1996US5547853 CD2-binding domain of lymphocyte function associated antigen 3
08/20/1996US5547678 Mixture of kojic acid and sunscreen agent
08/20/1996US5547662 Preparation of a skin surface for a surgical procedure
08/15/1996WO1996024371A1 Multifunctional enzyme
08/15/1996WO1996024359A1 Novel pharmaceutical formulation
08/15/1996WO1996024350A1 Pharmaceutical preparations for tumour necrosis factor (tnf) inhibition
08/15/1996WO1996011685A3 Use of indole derivatives for the treatment of various diseases
08/15/1996CA2212533A1 Multifunctional enzyme
08/15/1996CA2211409A1 Novel pharmaceutical formulation
08/14/1996EP0726273A1 Tocophenylglycoxides, their preparation and use as tensides, as antioxidants and as cells altering prophylactics in cosmetic or pharmaceutical preparation
08/14/1996EP0725796A1 Growth differentiation factor-10
08/14/1996EP0725772A1 Phytosphingosine-based ceramide i analogs
08/14/1996EP0725635A1 Phenylacetate and derivatives alone or in combination with other compounds against neoplastic conditions and other disorders
08/14/1996EP0725634A1 Plaster for the treatment of nail mycoses
08/14/1996EP0636115B1 Novel bis-phenyl-hexenes
08/14/1996CN1128660A Medicinal ointment for resolving blood stasis
08/13/1996US5545669 Anti-inflammatory compounds
08/13/1996US5545633 Triplet-sensitized photoisomerization; dehydration; protecting; deprotecting; separation
08/13/1996US5545405 Administering recombinant antibody glycosylated by chinese hamster ovary cell
08/13/1996US5545404 Method for treating a mammal suffering from a T-cell medicated disorder with a CHO-Glycosylated antibody
08/13/1996US5545403 Method for treating a mammal by administering a CHO-glycosylated antibody
08/08/1996WO1996023787A1 Substituted heterocyclic compounds, preparation method therefor and pharmaceutical compositions containing same
08/08/1996WO1996023512A1 Extracts of shark cartilage, process of production and uses thereof
08/08/1996WO1996023510A1 Effervescent composition containing iodinated polyvinylpyrrolidone, and use thereof for disinfection
08/08/1996WO1996023505A1 Inhibition of the degradation of connective tissue matrix protein components in mammals
08/08/1996WO1996023490A1 Formulations and methods for reducing skin irritation
08/08/1996WO1996023489A2 Use of carotinoids for preparing medicaments for treating dermatoses
08/08/1996WO1996023487A1 Medicament form for the delivery of collagenase to wounds and process for the preparation thereof
08/08/1996WO1996023463A1 Transdermal formulation
08/08/1996DE19503338A1 Arzneiform zur Abgabe von Kollagenase an Wunden und Verfahren zu ihrer Herstellung Dosage form for the delivery of collagenase to wounds and methods for their preparation
08/08/1996CA2212127A1 Formulations and methods for reducing skin irritation
08/08/1996CA2212059A1 Medicament form for the delivery of collagenase to wounds and process for the preparation thereof
08/08/1996CA2211783A1 Inhibition of the degradation of connective tissue matrix protein components in mammals
08/08/1996CA2211586A1 Effervescent composition containing iodinated polyvinylpyrrolidone, and use thereof for disinfection___________________________________________
08/08/1996CA2210957A1 The use of carotenoids for producing drugs for the treatment of dermatoses
08/08/1996CA2210711A1 Transdermal formulation
08/07/1996EP0724599A1 Platelet-derived growth factor analogues
08/07/1996EP0724597A1 Ks-laminin and methods of use
08/07/1996EP0724592A1 16-substituted-4-aza-androstane 5-alpha-reductase isozyme 1 inhibitors
08/07/1996EP0724566A1 1,2-diarylcyclopentenyl compounds for the treatment of inflammation
08/07/1996EP0724438A1 Ibuprofen and flurbiprofen as anti-pruritic agents
08/07/1996CN1128263A Pyrrolopyrimidine derivatives having pharmacological activity
08/07/1996CN1128262A Substituted biphenyl isoxazole sulfonamides
08/06/1996US5543422 Heterocyclic amines
08/06/1996US5543417 Combination method of treating acne using 4-AZA-5α-cholestan-ones and 4-AZA-5α-androstan-ones as selective 5α-reductase inhibitors with anti-bacterial, keratolytic, or anti-inflammatory agents
08/06/1996US5543410 Pharmacological use of phthaloylhydrazide derivatives; combination and application thereof
08/01/1996WO1996023068A1 A chemokine receptor able to bind to mcp-1, mip-1 alpha and/or rantes. its uses
08/01/1996WO1996023067A1 Human interleukin-1 receptor accessory protein
08/01/1996WO1996023065A2 Inhibition of neovascularization using vegf-specific oligonucleotides
08/01/1996WO1996022985A1 2-(2-amino-3-methoxyphenyl)-4-oxo-4h-[1]benzopyran for treating proliferative disorders
08/01/1996WO1996022776A1 Dermatological use of vitamin d derivatives
08/01/1996WO1996022760A2 Antagonists of alpha-melanocyte stimulating hormone and methods based thereon
08/01/1996CA2210884A1 Dermatological use of vitamin d derivatives
08/01/1996CA2210737A1 Antagonists of alpha-melanocyte stimulating hormone and methods based thereon
08/01/1996CA2210724A1 Human interleukin-1 receptor accessory protein
08/01/1996CA2208075A1 2-(2-amino-3-methoxyphenyl)-4-oxo-4h-[1]benzopyran for treating proliferative disorders
07/1996
07/31/1996EP0723959A1 Heterocyclic compounds as tachykinin receptor antagonists, process for their preparation and pharmaceuticals containing them
07/31/1996EP0723782A1 Use of a preparation comprising a plasminogen activator to improve wound healing
07/31/1996EP0723781A2 Transdermal formulation of xanomeline
07/31/1996EP0723778A1 Composition for modulation of apoptosis comprising a factor influencing the intracellular level of methional or malondialdehyde
07/31/1996EP0723774A1 Cosmetic, dermatological or pharmaceutical composition comprising an antagonist of CGRP
07/31/1996EP0723595A1 A novel nuclear mitotic phosphoprotein: mitosin
07/31/1996EP0647219B1 Derivatives in the vitamin d series modified at the 20 position, a method of preparing such derivatives, intermediates used in this method, pharmaceutical preparations containing the derivatives and their use in the preparation of drugs
07/31/1996CN1128047A Recombinant stratum corneum chymotryptic enzyme (SCCE)
07/31/1996CN1127653A "Jiexuanling" medicine for treating scabies
07/30/1996US5541219 Antiinflammatory agents; aids
07/30/1996US5541202 New leukotriene-B4 Antagonists and their use as pharmaceutical agents
07/30/1996US5541190 Treating benign prostatic hyperplasia, male pattern baldness, prostatic cancer, androgenic alopecia
07/30/1996US5541183 Ginkgolide derivatives
07/30/1996US5541073 Method of diagnosing epidermis differentiation disorders in a patient using a stratum corneum-specific antibody
07/30/1996CA1338493C Bicyclic aromatic derivatives; process for preparing the same and their use in cosmetics
07/25/1996WO1996022369A1 Analogs of acidic fibroblast growth factor having enhanced stability and biological activity
07/25/1996WO1996022306A1 Novel peptide
07/25/1996WO1996022021A1 Protein hydroxylation inhibitors for fibroproliferative disorders
07/25/1996CA2210885A1 Protein hydroxylation inhibitors for fibroproliferative disorders
07/24/1996EP0723015A1 Novel modified PF4 compositions and methods of use
07/24/1996EP0722928A1 Bicyclic-aromatic compounds with strong biologic activity, pharmaceutical and cosmetic compositions containing them and uses thereof
07/24/1996EP0722736A1 Topical composition containing an antagonist of substance P
07/24/1996EP0722722A1 Use of an antagonist of substance P for the treatment of cutaneous erythema of neurogenic origin
07/24/1996EP0722715A1 Cosmetic compositions containing lactate dehydrogenase inhibitors
07/24/1996EP0722451A1 Water-soluble retinoids
07/24/1996EP0722448A1 O-aryl, o-alkyl, o-alkenyl and o-alkynyl-macrolides having immunosuppressive activity
07/24/1996EP0722318A1 Chemically-defined non-polymeric valency platform molecules and conjugates thereof
07/24/1996EP0581954B1 Use of alpha-hydroxyketoalkyl derivatives as protective light filters
07/24/1996CN1127509A New peptide derivatives
07/24/1996CN1127258A Novel a-nor-steroid-3-carboxylic acid derivatives